Key questions of endocannabinoid signalling in the CNS: Which, where and when?

Journal of Physiology

Volumn 589, Issue 20, 2011, Pages 4807-4808

  Frazier, Charles J ^a,b  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; CANNABINOID 1 RECEPTOR; DIACYLGLYCEROL; ENDOCANNABINOID; ENZYME INHIBITOR; LIPOPROTEIN LIPASE;

4 AMINOBUTYRIC ACID RELEASE; ACTION POTENTIAL; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CORPUS STRIATUM; ENZYME INHIBITION; GENE DELETION; HIPPOCAMPUS; HUMAN; MOLECULAR MECHANICS; NERVE CELL PLASTICITY; NOTE; PREFRONTAL CORTEX; PRIORITY JOURNAL;

ANIMALS; ARACHIDONIC ACIDS; ENDOCANNABINOIDS; GLYCERIDES; INHIBITORY POSTSYNAPTIC POTENTIALS; LIPOPROTEIN LIPASE; MALE; NEURAL INHIBITION; POLYUNSATURATED ALKAMIDES; PREFRONTAL CORTEX;

EID: 80054109238     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2011.219493     Document Type: Note

References (5)

1. Alger BE & Kim J (2011). Trends Neurosci 34, 304-315.
2. Gao Y, Vasilyev DV, Goncalves MB, Howell FV, Hobbs C, Reisenberg M, Shen R, Zhang MY, Strassle BW, Lu P, Mark L, Piesla MJ, Deng K, Kouranova EV, Ring RH, Whiteside GT, Bates B, Walsh FS, Williams G, Pangalos MN, Samad TA & Doherty P (2010). J Neurosci 30, 2017-2024.
3. Min R, Di Marzo V & Mansvelder HD (2010). Neuroscientist 16, 608-613.
4. Tanimura A, Yamazaki M, Hashimotodani Y, Uchigashima M, Kawata S, Abe M, Kita Y, Hashimoto K, Shimizu T, Watanabe M, Sakimura K & Kano M (2010). Neuron 65, 320-327.
5. Yoshino H, Miyamae T, Hansen G, Zambrowicz B, Flynn M, Pedicord D, Blat Y, Westphal RS, Zaczek R, Lewis DA & Gonzalez-Burgos G (2011). J Physiol 589, 4857-4884.